Clinically researched to support effective, stimulant-free weight management through proven metabolic science.
Clinically researched to support effective, stimulant-free weight management through proven metabolic science.
LLP‑1 incorporates a blend of viscous polysaccharides and esterified fatty acids, formulated to support satiety and metabolic regulation.
often called the “satiety hormone,” produced by fat cells, signals to the brain when we are full.
Another hormone from fat cells that helps with fat‑burning and glucose utilization; higher adiponectin tends to favour healthier metabolism.
In the clinical study, LLP‑1 supplementation was associated with reduced serum leptin and increased adiponectin, compared with placebo. These results suggest improved satiety signalling and metabolic responsiveness.
22 women (11 taking LLP‑1 and 11 placebo) with average BMI ~32.7, over 8 weeks with diet + exercise.
Average fat loss ~21.3 lbs in LLP‑1 group vs ~10.8 lbs in placebo. Waistline reduction ~3.9 inches vs ~1.9 inches.
Well tolerated, no digestive discomfort commonly seen with other satiety/weight‑management approaches.
LLP‑1 is water‑dispersible and neutral in flavour, making formulation simpler across formats.
Disclaimer: Information provided is for educational purposes only; it is not intended to diagnose, treat, cure or prevent any disease. Regulatory compliance and region‑specific claims must be checked with legal counsel.
